DAFNA Capital Management »

Verrica Pharmaceuticals shares owned by DAFNA Capital Management

Quarter-by-quarter ownership of Verrica Pharmaceuticals (VRCA) shares owned by DAFNA Capital Management from 13F filings

Historical chart of DAFNA Capital Management investment in Verrica Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Verrica Pharmaceuticals held by DAFNA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verrica Pharmaceuticals by DAFNA Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.4M 174k 8.31

More positions owned by DAFNA Capital Management

Revolution Medicines (RVMD)
Spdr S&p Biotech Etf Etf (XBI)
Stereotaxis Com New (STXS)
AtriCure (ATRC)
Cytokinetics Com New (CYTK)
Ideaya Biosciences (IDYA)
Axogen (AXGN)
Xenon Pharmaceuticals (XENE)
Ishares Nasdaq Biotech Indx Etf (IBB)
Biohaven (BHVN)
Arcus Biosciences Incorporated (RCUS)
Neurocrine Biosciences (NBIX)
Day One Biopharmaceuticals I (DAWN)
Tandem Diabetes Care Com New (TNDM)
Ascendis Pharma A/s Sponsored Adr (ASND)

View all positions for DAFNA Capital Management

Top funds holding Verrica Pharmaceuticals

Caligan Partners
Affinity Asset Advisors
Armistice Capital
Stonepine Capital Management
Boothbay Fund Management
DAFNA Capital Management
Vanguard Group
Jane Street
Marshall Wace
Millennium Management
Geode Capital Management
Squarepoint Ops
Sovran Advisors
Renaissance Technologies
Mariner Wealth Advisors

View all funds holding Verrica Pharmaceuticals